Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.
In 2019, the market size of Human Platelet Lysate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Platelet Lysate.
This report studies the global market size of Human Platelet Lysate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Platelet Lysate production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Mill Creek Life Sciences
Merck & Co., Inc
STEMCELL Technologies Inc
AventaCell BioMedical
Compass Biomedical, Inc
Macopharma SA
Trinova Biochem GmbH
PL BioScience GmbH
Cook Regentec
Market Segment by Product Type
Heparin
Heparin free
Market Segment by Application
Biopharmaceutical companies
Contract research organizations
Academic & research institutes
Pharmaceutical companies
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Human Platelet Lysate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Platelet Lysate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Human Platelet Lysate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on HumanPlateletLysate. Industry analysis & Market Report on HumanPlateletLysate is a syndicated market report, published as Global (United States, European Union and China) Human Platelet Lysate Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of HumanPlateletLysate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.